How to register a medical device in Costa Rica with MINSA (RTCR 505:2022)

Sponsors still write “Costa Rica registration” as if the Ministerio de Salud ran one switch for trials and commercial sale. It does not. Equipo y Material Biomédico (EMB) gets onto the Costa Rican market under Reglamento Técnico RTCR 505:2022 through the Regístrelo portal. A CONIS / CEC clinical-trial file is not a license to sell.

I am Julio Martinez-Clark, CEO of bioaccess®. This page is the commercial Costa Rica file: how a medical device gets registered under RTCR 505:2022, when Class I is exempt, what a single Costa Rica Registration Holder (CRH) can and cannot do, and how that desk stays off the first-in-human critical path. It sits next to our LATAM market-access hub, the Costa Rica MoH country page, and the Importer of Record guide. Operator guidance only. Not a quote and not legal advice.

One-sentence answer

Commercial sale of Class 2, 3 and 4 EMB in Costa Rica requires sanitary registration with the Ministerio de Salud’s Dirección de Regulación de Productos de Interés Sanitario under Reglamento Técnico RTCR 505:2022 (“Equipo y Material Biomédico. Clasificación, Registro, Importación, Etiquetado, Publicidad, Vigilancia y Control”), filed online through Regístrelo under Decreto Ejecutivo N° 37988-S and Ley General de Salud N° 5395, with a single registered title holder (CRH) who may authorize downstream distributors on that registration. Class 1 EMB is exempt from sanitary registration under Decreto N° 41387-S, subject to labeling and control rules that still apply.

Two Costa Rica desks — write them on separate pages

Investigational use. Protocol review through an accredited CEC, CONIS registration, and the Ley 9234 research framework. That path is for first-in-human and other clinical research. It is not a commercial registro. See our Costa Rica FIH activation and CONIS coverage pages.

Commercial registro. Manufacture, import, commercialization or distribution of EMB that already has a clearance story elsewhere (often FDA or CE) follows RTCR 505:2022. Risk class drives whether you file at all and what goes in the dossier. The named CRH is the regulatory face of the product.

If your Gantt has one bar labeled “MINSA / MoH,” you do not have a plan. Trial units and commercial units are different petitions.

What RTCR 505:2022 actually covers

RTCR 505:2022 sets classification, registration, import, labeling, advertising, vigilance and control for EMB destined for human use in Costa Rica. It reaches products manufactured in-country, imports for commercialization or use, sale and distribution, advertising, labeling, and software / medical apps when they are EMB.

Operator anchors we use when we open a Costa Rica folder:

  • Class 1: exempt from sanitary registration (Decreto N° 41387-S). Labeling and other control duties still apply — exemption is not “no rules.”
  • Class 2, 3 and 4: sanitary registration required before commercialization.
  • Filing channel: Regístrelo (www.registrelo.go.cr), with digital signature, under Decreto Ejecutivo N° 37988-S.
  • Foreign documents: apostilled or legalized, then notarially certified for Regístrelo upload; Spanish translation when the original is not in Spanish.
  • Validity: the Ministry’s public EMB page states a five-year sanitary registration term. Plan renewal before expiry; do not treat the certificate as perpetual.

What the single CRH model means

Costa Rica names one registered title holder on the sanitary registration. That CRH is the regulatory anchor. RTCR 505:2022 and the live Importer of Record guide confirm the CRH (or the product title holder / legal representative) can authorize third parties for importation or distribution when that authorization is indicated in the registration request — so multiple downstream distributors can sit under one registration without splitting titularidad.

Design implication for US and European manufacturers: do not put the first commercial distributor on the certificate if you want a clean channel change later. Hold the CRH seat with an entity that answers to the manufacturer’s transfer doctrine, then authorize distributors underneath that holder.

What belongs in the commercial dossier (operator list)

Exact Regístrelo forms move with Ministry practice. The working stack sponsors assemble before translators start is stable:

  • Device identity, intended use, and RTCR risk class as the Ministry will see it
  • Manufacturer and manufacturing sites, with quality-system evidence appropriate to class (good-manufacturing / equivalent certificate for Class 2+, apostilled)
  • Free-sale / marketing-authorization evidence from a reference country when the class requires it
  • Technical and medical specifications, manuals and inserts for the configuration you will sell in Costa Rica — Spanish when the original is not
  • Clinical evidence of safety and performance for Class 3 (and higher-risk Class 4) filings, with Spanish translation when needed
  • CRH appointment / poder de representación with clear powers and term
  • Labels and IFU in Spanish matching the sellable configuration

Electrical / EMC or RF homologation for wireless devices, when required, runs through Costa Rica’s telecom authority as a separate vendor track. Do not bury that inside the sanitary clock.

What this file is not

  • It is not a CONIS / CEC clinical-trial authorization. Trial units enter under the research path; commercial units enter under RTCR 505:2022 registro.
  • It is not a Class 1 free-for-all. Exemption from registro still leaves labeling and control duties.
  • It is not a free pass to treat a Costa Rica FIH as proof of market clearance. First patient in and sanitary registration are different end states.

How bioaccess® runs the Costa Rica holder seat

On the live market-access offer, bioaccess® acts as the Costa Rica Registration Holder through our own Costa Rican entity for sanitary registration, importer-of-record duties where the CRH imports under the registration, certified Spanish translations, government fees, and vigilance as holder. Pricing for the LATAM Launch Subscription is published on bioaccessla.com/market-access (USD 7,500 per year per country for the first device family; additional families at the published add-on rates). Timelines are confirmed at proposal against the current Regístrelo / Ministry queue — we do not invent a statutory day-count here.

Operator checklist before you open a Costa Rica registro folder

  1. Write “trial” and “registro” on two pages. Put owners and statutes on each page.
  2. Confirm class: Class 1 exempt vs Class 2/3/4 registro.
  3. Decide the CRH before you pick a distributor.
  4. Confirm the configuration you will sell matches the Spanish labels and IFU you will file — not the investigational configuration from an FIH.
  5. Budget apostille / legalization and digital-signature logistics into the Regístrelo calendar.
  6. Budget RF / telecom tracks separately when the device is wireless.

Talk with bioaccess® when you need Costa Rica registro held independent of the commercial channel — or when you are sequencing a Costa Rica FIH into a later MoH market file without mixing the desks.